Imaging assessment of the responses of osteosarcoma patients to preoperative chemotherapy: Angiography compared with thallium-201 scintigraphy

Cancer

Volumn 86, Issue 6, 1999, Pages 949-956

  Kunisada, Toshiyuki ^a   Ozaki, Toshifumi ^a   Kawai, Akira ^a   Sugihara, Shinsuke ^a   Taguchi, Kohji ^b   Inoue, Hajime ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OKAYAMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Angiography; Chemotherapy; Osteosarcoma; Scintigraphy; Thallium 201

Indexed keywords

CISPLATIN; DOXORUBICIN; IFOSFAMIDE; METHOTREXATE; THALLIUM 201;

ADOLESCENT; ADULT; ARTICLE; BONE SCINTISCANNING; CANCER CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; DIGITAL SUBTRACTION ANGIOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MALE; OSTEOSARCOMA; PREOPERATIVE PERIOD; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANGIOGRAPHY, DIGITAL SUBTRACTION; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; FEMORAL NEOPLASMS; HISTOLOGICAL TECHNIQUES; HUMANS; MALE; OSTEOSARCOMA; PREOPERATIVE CARE; RADIOPHARMACEUTICALS; THALLIUM RADIOISOTOPES; TIBIA;

EID: 0033568155     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990915)86:6<949::AID-CNCR9>3.0.CO;2-H     Document Type: Article

References (35)

1. Link MP, Goorin AM, Miser AW, Green AA, Pratt CB, Belasco JB, et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 1986;314:1600-6.
2. Bacci G, Sprnigfield D, Capanna R, Picci P, Guerra A, Albissini U, et al. Neoadjuvant chemotherapy for osteosarcoma of the extremity. Clin Orthop 1987;224:268-76.
3. Rosen G, Caparros B, Huvos AG, Kosloff C, Nirenberg A, Cacavio A, et al. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 1982;49:1221-30.
4. Meyers PA, Heller G, Healey J, Huvos A, Lane J, Marcove R, et al. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol 1992; 10:5-15.
5. Winkler K, Bielack S, Delling G, Salzer-Kuntschik M, Kotz R, Greenshaw C, et al. Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorucin, high-dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (Study COSS-86). Cancer 1990;66:1703-10.
6. Hudson M, Jaffe MR, Ayala A, Raymond AK, Carrasco H, Wallace S, et al. Pediatric osteosarcoma: therapeutic strategies, results and prognostic factors derived from a 10-year experience. J Clin Oncol 1990;8:1988-97.
7. Raymond AG, Chawla SP, Carrasco H, Ayala AG, Fanning CV, Grice B, et al. Osteosarcoma chemotherapy effect: a prognostic factor. Semin Diagn Pathol 1987;4:212-36.
8. Davis AM, Bell RS, Goodwin PJ. Prognostic factors in osteosarcoma: a critical reveiw. J Clin Oncol 1994;12:423-31.
9. Riebel T, Lassrich MA, Kumpan W. Roentgenologic follow-up in primarily conservatively treated osteogenic sarcoma. J Cancer Res Clin Oncol 1983;106(Suppl):38-42.
10. Smith J, Heelan RT, Huvos AG, Caparros B, Rosen G, Urmacher C, et al. Radiographic changes in primary osteogenic sarcoma following intensive chemotherapy. Radiology 1982; 143:355-60.
11. Wellings RM, Davies AM, Pynsent PB, Carter SR, Grimer RJ. The value of computed tomographic measurements in osteosarcoma as a predictor of response to adjuvant chemotherapy. Clin Radiol 1994;49:19-23.
12. Holscher HC, Bloem JL, Van der Woude HJ, Hermans J, Nooy MA, Taminiau AHM, et al. Can MRI predict the histopathological response in patients with osteosarcoma after the first cycle of chemotherapy? Clin Radiol 1995;50: 384-90.
13. Carrasco CH, Charnsangavej C, Raymond AK, Richli WR, Wallace S, Chawla SP, et al. Osteosarcoma: angiographic assessment of response to preoperative chemotherapy. Radiology 1989;170:839-42.
14. Kumpan W, Lechner G, Wittich GR, Salzer-Kuntschik M, Delling G, Kotz R, et al. The angiographic response of osteosarcoma following pre-operative chemotherapy. Skeletal Radiol 1986;15:96-102.
15. Menendez LR, Fideler BM, Mirra J. Thallium-201 scanning for the evaluation of osteosarcoma and soft-tissue sarcoma. J Bone Joint Surg 1993;75A:526-31.
16. 201Tl uptake in tumours. Eur J Nucl Med 1989;15:376-9.
17. Kawai A, Sugihara S, Kunisada T, Uchida Y, Inoue H. Imaging assessment of the response of bone tumors to preoperative chemotherapy. Clin Orthop 1997;337:216-25.
18. Fujii J, Ozaki T, Kunisada T, Kawai A, Inoue H. Angiography for assessment of preoperative chemotherapy in musculoskeletal sarcomas. Clin Orthop. 1999;360:197-206.
19. 99mTc-HMDP scintigraphy in 34 cases. Acta Orthop Scand 1998;69:611-6.
20. Uchida Y, Ozaki T, Kawai A, Kunisada T, Dan'ura T, Naito N, et al. Effect of dose intensity of methotrexate, doxorubicin, and ifosfamide on the prognosis of patients with osteosarcoma. Int J Clin Oncol 1999;4:36-40.
21. Rosen G, Loren GJ, Brien EW, Ramana L, Waxman A, Lowenbraun S, et al. Serial thallium-201 scintigraphy in osteosarcoma: correlation with tumor necrosis after preoperative chemotherapy. Clin Orthop 1993;293:302-6.
22. Ma LD, Frassica FJ, McCarthy EF, Bluemke DA, Zerhouni EA. Benign and malignant musculoskeletal masses: MR imaging differentiation with rim-to-center differential enhancement ratios. Radiology 1997;202:739-44.
23. Goorin AM, Andersen JW. Experience with multiagent chemotherapy for osteosarcoma: improved outcome. Clin Orthop 1991;270:22-8.
24. Rosen G. Neoadjuvant chemotherapy for osteogenic sarcoma: a model for the treatment of other highly malignant neoplasms. Recent Results Cancer Res 1986;103:148-57.
25. Mail JT, Cohen MD, Mirkin LD, Provisor AL. Response of osteosarcoma to preoperative intravenous high-dose methotrexate chemotherapy: CT evaluation. Am J Roentgenol 1985;144:89-93.
26. Pan G, Raymond AK, Carrasco C, Wallace S, Kim EE, Shirkhoda A, et al. Osteosarcoma: MR imaging after preoperative chemotherapy. Radiology 1990;174:517-26.
27. Panicek DM, Schwartz LH, Heelan RT, Caravelli JF. Non-neoplastic causes of high signal intensity at T2-weighted MR imaging after treatment for musculoskeletal neoplasm. Skeletal Radiol 1995;24:185-90.
28. Sanchez RB, Quinn SF, Walling A, Estrada J, Greenberg H. Musculoskeletal neoplasms after intraarterial chemotherapy: correlation of MR images with pathologic specimens. Radiology 1990;174:237-40.
29. Lamki LM. Tissue characterization in nuclear oncology: its time has come. J Nucl Med 1995;36:207-10.
30. Salvatore M, Carratœ L, Porta E. Thallium-201 as a positive indicator for lung neoplasms: preliminary experiments. Radiology 1976;121:487-8.
31. Lin J, Leung W, Ho SKW, Kumta SM, Metreweli C, Johnson PJ. Quantitative evaluation of thallium-201 uptake in predicting chemotherapeutic response of osteosarcoma. Eur J Nucl Med 1995;22:553-5.
32. 99mTc-diphosphonate in relation to local bone blood flow. Radiology 1976;120:121-3.
33. Genant HK, Bautovich GJ, Singh M, Lathrop KA, Harper PV. Bone-seeking radionuclides: an in vivo study of factors affecting skeletal uptake. Radiology 1974;113:373-82.
34. Ohtomo K, Terui S, Yokoyama R, Abe H, Terauchi T, Maeda G, et al. Thallium-201 scintigraphy to assess effect of chemotherapy in osteosarcoma. J Nucl Med 1996;37:1444-8.
35. Imbriaco M, Yeh SDJ, Yeung H, Zhang JJ, Healey JH, Meyers P, et al. Thallium-201 scintigraphy for the evaluation of tumor response to preoperative chemotherapy in patients with osteosacoma. Cancer 1997;80:1507-12.